HOTH — HOTH THERAPEUTICS INC

Ownership history in UBS Group AG  ·  25 quarters on record

This page tracks every 13F SEC filing in which UBS Group AG reported a position in HOTH THERAPEUTICS INC (HOTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 58,341 -36,324 -38.4% 0.00% $58K $0.99
2025 Q3 ADDED 94,665 +52,425 +124.1% 0.00% $153K $1.62
2025 Q2 REDUCED 42,240 -16,518 -28.1% 0.00% $49K $1.17
2025 Q1 ADDED 58,758 +27,765 +89.6% 0.00% $59K $1.00
21 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HOTH price (monthly, adj. close)

Other funds also holding HOTH

As of 2025 Q4 — sorted by position size

DRW Securities, LLC 3Y 7Y 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% Lido Advisors, LLC 3Y 7Y 0.0% FLAGSHIP HARBOR ADVISORS, LLC 3Y 7Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% SUSQUEHANNA INTERNATIONAL GROUP, LLP 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0%
← Back to UBS Group AG Holdings